oric-101
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 19, 2017 (NCT03324555)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Glucocorticoid receptorINHIBITOR
NR3C1 inhibitor
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4802177 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04033328 | Phase 1 | Sep 30, 2019 | Oric Pharmaceuticals |
| NCT03928314 | Phase 1 | May 2, 2019 | Oric Pharmaceuticals |
| NCT03835637 | Phase 1 | Mar 23, 2018 | Oric Pharmaceuticals |
| NCT03324555 | Phase 1 | Oct 19, 2017 | Oric Pharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Oric Pharmaceuticals | For profit | 4 | 4 | 1 | 2017 |
1 organizations
Page 1 / 1